Clinical Trial Update: Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder [Phase 2]

View source ↗

Summary

An early Phase 2 study of TS-142 for insomnia disorder has completed, according to the trial update; no results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia Disorder

Drugs mentioned

• TS-142

Snippet

Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Insomnia Disorder | Phase 2 | Status: COMPLETED